Multiplexed detection and quantitation of T1D-relevant autoantibodies holds significant promise for improving patient outcomes
As an invited keynote speaker at today’s MedInnovations meeting, Wave 80’s Dan Laser described the role for key emerging technologies in the life sciences. In a subsequent panel [...]
Grant by United States Patent and Trademark Office covers groundbreaking Wave 80 technology for high-performance molecular assays, liquid biopsy, and other applications.
As part of the occasional Amgen Innovator Series featuring high-profile Bay Area life sciences leaders, Wave 80 founder Dan Laser spoke today at the California Institute for Quantitative [...]
Joint Keynote Speech at Tuberculosis Workshop Given by Wave 80 Founder and Leading Kenyan Pharmaceuticals Executive
0 0
Washington, DC, April 6, 2016—At a major gathering of leaders in the tuberculosis field, held in Washington DC, Wave 80 founder and Board of Directors chairman Dr. Daniel Laser was joined by Palu [...]
Featured Presentation at Sample Preparation Conference Highlights Wave 80’s Technological Leadership
0 0
Dr. Shan Gao, a senior member of Wave 80’s technical staff, to speak on high-efficiency extraction of genomic material from challenging samples without centrifugation.
Wave 80 Scientist Co-Authors Journal Article Highlighting Challenges, Opportunities in Clinical Laboratory Testing for Infectious Disease
0 0
Dr. Laura Mazzola, Wave 80’s Senior Vice President of Global Initiatives, co-authors analysis of impact and opportunities for new diagnostics technologies.
Collaboration to explore new ways of using magnetic detection in high-performance enclosed-cartridge-format assays.